ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one ...

ARS Pharmaceuticals has a recently launched needle-free epinephrine product for allergic reactions, neffy. See why I rate ...

Feb. 27, 2025 — A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the ...

Can’t breathe without your nasal spray? You’re not alone. But here’s why that quick fix can cause long-term harm.

The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression.

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...

Astepro is a nasal spray with antihistamine, which Rubin usually recommends pairing with a steroid spray. Steroid nasal ...